Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| ECM-receptor interaction | R-HSA-373711 | map04512 | trichostatin A | 441383 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | trichostatin A | 441383 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | trichostatin A | 441383 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | trichostatin A | 441383 | drug-path |
| Basal cell carcinoma | R-HSA-5626181 | map05217 | trichostatin A | 441383 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | trichostatin A | 441383 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | trichostatin A | 441383 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | trimetazidine | 36294 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | trimetazidine | 36294 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | trimetazidine | 36294 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | trimetazidine | 36294 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | trimetazidine | 36294 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | trimetazidine | 36294 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | trimetazidine | 36294 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | trimetazidine | 36294 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | trimetazidine | 36294 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | trimetazidine | 36294 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | trimetazidine | 36294 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | thiocolchicoside | 5430 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | thiocolchicoside | 5430 | drug-path |